Skip to content

Kelly Allott

Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.

2 papers in the library · 9 citations · publishing 2023-2025

Papers

The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosis

Early Intervention in Psychiatry July 2, 2023 Marija Krcmar, Cassandra Wannan, Suzie Lavoie et al. 6 citations

Basic self-disturbance is a potential core vulnerability marker for schizophrenia spectrum disorders. The Self, Neuroscience and Psychosis (SNAP) study tests a neurophenomenological model of psychosis by examining clinical, neurocognitive, and neurophysiological variables in individuals at ultra-high risk (UHR) for psychosis. It includes 400 UHR individuals, 100 clinical controls without attenuated psychotic symptoms, and 50 healthy controls. Participants complete baseline assessments and electroencephalography; UHR participants are followed for 24 months with clinical assessments every 6 months. The protocol aims to develop a prediction model for persistence or worsening of UHR symptoms at 12 months and to determine how specific these disturbances are to attenuated psychotic symptoms.

The neurophenomenology of basic self-disturbance in early psychosis: Association with clinical outcome in an ultra-high risk sample.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists August 1, 2025 Vera A Barata, Suzie Lavoie, Łukasz Gawęda et al. 3 citations

Among 43 individuals at ultra-high risk for psychosis, those who later remitted had lower baseline levels of basic self-disturbance than those whose symptoms persisted or who transitioned to psychosis. Basic self-disturbance scores predicted worse clinical outcomes at 12 months. Source monitoring deficits were greater in first-episode psychosis patients than in those at ultra-high risk whose symptoms persisted or transitioned. The findings suggest that high levels of basic self-disturbance may serve as a predictor of poor prognosis in ultra-high risk patients.